WENDY MIGLIORE SANCHEZ: Open Payments
NPI 1104199603 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,299 in 165 payments from 50 companies in 2025. Trend: 2023 $3,707 · 2024 $2,520 · 2025 $4,299
Food & beverage: $4,199Education: $116
| Company | Payments | Amount |
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 5 | $400 |
| Novartis Pharmaceuticals Corporation | 11 | $271 |
| Janssen Biotech, Inc. | 12 | $254 |
| Gilead Sciences, Inc. | 10 | $204 |
| AstraZeneca Pharmaceuticals LP | 6 | $176 |
| ABBVIE INC. | 8 | $174 |
| Merck Sharp & Dohme LLC | 7 | $168 |
| Daiichi Sankyo Inc. | 6 | $163 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $148 |
Products named: TAVALISSE, Enhertu, Trodelvy, Fyarro, CAPLYTA, CARVYKTI, RYBREVANT, AYVAKIT.
Industry payments across FL — which companies pay providers there.
